13F-HR filed by Tri Locum Partners LP
Tri Locum Partners LP filed this 13F-HR for the quarter ended 2024-03-31, filed 2024-05-15, with 27 holding rows worth $288,365,187.
- Accession
- 0001826434-24-000004
- Filer
- CIK 1826434
- Filed
- 2024-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2024
A holdings report, 27 entries on the cover page, a total value of $288,365,187 stated on the cover page (in dollars after the unit check, H1), rows summing to $288,365,187 with VALUE read as dollars as filed, 13F file number 028-21000. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 2,216,188 | $31,270,413 | dollars as filed | |
| AVADEL PHARMACEUTICALS, PLC | 05337M104 | COMMON STOCK-FO | 1,189,511 | $20,090,841 | dollars as filed | |
| SILK ROAD MEDICAL INC | 82710M100 | COMMON STOCK | 1,083,605 | $19,851,644 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 190,114 | $17,387,826 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 112,670 | $17,032,324 | dollars as filed | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 283,773 | $15,916,828 | dollars as filed | |
| Merck & Co.,Inc. | 58933Y105 | COM | 119,200 | $15,728,440 | dollars as filed | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 35,598 | $14,880,320 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 53,355 | $14,247,919 | dollars as filed | |
| BAXTER INTL INC | 071813109 | COM | 317,566 | $13,572,771 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 286,322 | $12,893,080 | dollars as filed | |
| TANDEM DIABETES CARE INC | 875372203 | COM NEW | 326,506 | $11,561,577 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 27,981 | $11,016,679 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 207,465 | $8,931,368 | dollars as filed | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 8,567 | $8,245,652 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 102,711 | $8,196,338 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 106,494 | $6,498,264 | dollars as filed | |
| EXACT SCIENCES CORP COM | 30063P105 | Stock | 90,000 | $6,215,400 | dollars as filed | |
| LYRA THERAPEUTICS INC | 55234L105 | COM | 978,793 | $6,088,092 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 369,549 | $5,201,402 | dollars as filed | |
| INSPIRE MED SYS INC COM | 457730109 | Stock | 23,566 | $5,061,741 | dollars as filed | |
| ALPINE IMMUNE SCIENCES INC | 02083G100 | COM | 120,687 | $4,784,033 | dollars as filed | |
| ARCTURUS THERAPEUTICS HLDGS | 03969T109 | COM | 138,927 | $4,691,565 | dollars as filed | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 449,694 | $4,456,468 | dollars as filed | |
| MIND MEDICINE MINDMED INC | 60255C885 | COM NEW | 379,596 | $3,568,202 | dollars as filed | |
| PERSPECTIVE THERAPEUTICS INC | 46489V104 | COM | 780,303 | $928,561 | dollars as filed | |
| FEMASYS INC | 31447E105 | cs | 30,606 | $47,439 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001826434-24-000004 | this filing | 2024-05-15 | acceptance time not in the bulk data set |